These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
597 related articles for article (PubMed ID: 34575965)
1. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. Bule P; Aguiar SI; Aires-Da-Silva F; Dias JNR Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575965 [TBL] [Abstract][Full Text] [Related]
2. Chemokines in cancer. Chow MT; Luster AD Cancer Immunol Res; 2014 Dec; 2(12):1125-31. PubMed ID: 25480554 [TBL] [Abstract][Full Text] [Related]
3. Chemokines and the immune response to cancer. Ozga AJ; Chow MT; Luster AD Immunity; 2021 May; 54(5):859-874. PubMed ID: 33838745 [TBL] [Abstract][Full Text] [Related]
4. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nagarsheth N; Wicha MS; Zou W Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670 [TBL] [Abstract][Full Text] [Related]
5. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment. Susek KH; Karvouni M; Alici E; Lundqvist A Front Immunol; 2018; 9():2159. PubMed ID: 30319622 [TBL] [Abstract][Full Text] [Related]
6. Multifaceted role of chemokines in solid tumors: From biology to therapy. Raza S; Rajak S; Tewari A; Gupta P; Chattopadhyay N; Sinha RA; Chakravarti B Semin Cancer Biol; 2022 Nov; 86(Pt 3):1105-1121. PubMed ID: 34979274 [TBL] [Abstract][Full Text] [Related]
7. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy. Vilgelm AE; Richmond A Front Immunol; 2019; 10():333. PubMed ID: 30873179 [TBL] [Abstract][Full Text] [Related]
8. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy. Albini A; Bruno A; Noonan DM; Mortara L Front Immunol; 2018; 9():527. PubMed ID: 29675018 [TBL] [Abstract][Full Text] [Related]
9. Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy. Jung H; Paust S Front Immunol; 2024; 15():1443366. PubMed ID: 39114657 [TBL] [Abstract][Full Text] [Related]
10. Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration. Jin J; Zhao Q Theranostics; 2020; 10(14):6231-6244. PubMed ID: 32483450 [TBL] [Abstract][Full Text] [Related]
11. Regulation of chemokine expression in the tumor microenvironment. Gorbachev AV; Fairchild RL Crit Rev Immunol; 2014; 34(2):103-20. PubMed ID: 24940911 [TBL] [Abstract][Full Text] [Related]
12. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer. Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677 [TBL] [Abstract][Full Text] [Related]
13. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. Saxena S; Singh RK Cancer Metastasis Rev; 2021 Jun; 40(2):447-476. PubMed ID: 33959849 [TBL] [Abstract][Full Text] [Related]
14. The chemokine network: a target in cancer biology? Slettenaar VI; Wilson JL Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642 [TBL] [Abstract][Full Text] [Related]
15. Chemokines in angiogenesis. Dimberg A Curr Top Microbiol Immunol; 2010; 341():59-80. PubMed ID: 20373091 [TBL] [Abstract][Full Text] [Related]
16. Utilizing chemokines in cancer immunotherapy. Märkl F; Huynh D; Endres S; Kobold S Trends Cancer; 2022 Aug; 8(8):670-682. PubMed ID: 35501268 [TBL] [Abstract][Full Text] [Related]
17. Reversing chemokine/chemokine receptor mismatch to enhance the antitumor efficacy of CAR-T cells. Zhang PF; Wang C; Zhang L; Li Q Immunotherapy; 2022 Apr; 14(6):459-473. PubMed ID: 35232284 [TBL] [Abstract][Full Text] [Related]
18. The Complexity of Targeting Chemokines to Promote a Tumor Immune Response. Strazza M; Mor A Inflammation; 2020 Aug; 43(4):1201-1208. PubMed ID: 32314127 [TBL] [Abstract][Full Text] [Related]
19. Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy. Mollica Poeta V; Massara M; Capucetti A; Bonecchi R Front Immunol; 2019; 10():379. PubMed ID: 30894861 [TBL] [Abstract][Full Text] [Related]
20. Chemokines in bone-metastatic breast cancer: Therapeutic opportunities. Wang Y; Ren S; Wang Z; Wang Z; Zhu N; Cai D; Ye Z; Ruan J Int Immunopharmacol; 2020 Oct; 87():106815. PubMed ID: 32711376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]